(VIANEWS) – IBA (IBAB.BR), B&S Group (BSGR.AS), SANOFI (SAN.PA) are the highest payout ratio stocks on this list.
Here’s the data we’ve collected of stocks with a high payout ratio so far. The payout ratio in itself isn’t a guarantee of a future good investment but it’s an indicator of whether dividends are being paid and how the company chooses to issue them.
When researching a potential investment, the dividend payout ratio is a good statistic to know so here is a list of some companies with an above 30% payout ratio.
1. IBA (IBAB.BR)
94.67% Payout Ratio
Ion Beam Applications SA develops, manufactures, and supports medical devices and software solutions for cancer treatments in Belgium, the United States, and internationally. The company operates through Proton Therapy and Other Accelerators, and Dosimetry segments. The Proton Therapy and Other Accelerators segment develops, fabricates, and services medical and industrial particle accelerators, and proton therapy systems. This segment also offers turnkey solutions for the treatment of cancer through the use of proton beams; and a line of cyclotrons used for the production of positron emission tomography or SPECT radioisotopes, as well as a line of industrial accelerators for sterilization and ionization. The Dosimetry segment provides solutions and services that enhances efficiency and minimizes errors in radiation therapy and medical imaging quality assurance and calibration procedures. The company has strategic research and development partnership with SCK CEN (Belgian nuclear research center) to enable the production of Actinimum-225 (225Ac), a novel radioisotope for the treatment of cancer; and an agreement with University of Pennsylvania for research in ConformalFLASH. It also has a research partnership with Particle Therapy Interuniversity Center Leuven for the development of ConformalFLASH1. Ion Beam Applications SA was incorporated in 1986 and is headquartered in Louvain-la-Neuve, Belgium.
Earnings Per Share
As for profitability, IBA has a trailing twelve months EPS of €-0.68.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -21.17%.
Volume
Today’s last reported volume for IBA is 9431 which is 79.3% below its average volume of 45577.
Moving Average
IBA’s value is way above its 50-day moving average of €9.49 and way under its 200-day moving average of €14.08.
Yearly Top and Bottom Value
IBA’s stock is valued at €10.84 at 06:10 EST, way below its 52-week high of €18.66 and way higher than its 52-week low of €8.26.
Revenue Growth
Year-on-year quarterly revenue growth grew by 5.9%, now sitting on 370.66M for the twelve trailing months.
More news about IBA.
2. B&S Group (BSGR.AS)
50% Payout Ratio
B&S Group S.A. distributes consumer goods worldwide. The company operates through six segments: B&S Liquors, B&S Beauty, B&S Personal Care, B&S Food, B&S Health, and B&S Retail. The B&S Liquors segment distributes branded liquors to wholesalers, consumers, and e-commerce platforms. The B&S Beauty segment distributes and sells branded fragrances and cosmetics to wholesalers, consumers, and e-commerce platforms. The B&S Personal Care segment distributes and sells branded personal and home care products to retailers. The B&S Food segment distributes a range of branded food and beverages products to duty-free, remote, retail, and maritime markets. The B&S Health segment distributes and sells branded medical products and equipment to maritime and remote markets, pharmacies, and travel clinics. The B&S Retail segment offers consumer electronics and multi-category assortments for consumers at travel locations. The company was founded in 1872 and is based in Betzdorf, Luxembourg.
Earnings Per Share
As for profitability, B&S Group has a trailing twelve months EPS of €0.24.
PE Ratio
B&S Group has a trailing twelve months price to earnings ratio of 16.6. Meaning, the purchaser of the share is investing €16.6 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.7%.
Moving Average
B&S Group’s value is way higher than its 50-day moving average of €3.57 and above its 200-day moving average of €3.85.
Yearly Top and Bottom Value
B&S Group’s stock is valued at €3.99 at 06:10 EST, way under its 52-week high of €5.77 and way higher than its 52-week low of €3.16.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on May 24, 2023, the estimated forward annual dividend rate is 0.12 and the estimated forward annual dividend yield is 3.05%.
Volume
Today’s last reported volume for B&S Group is 99981 which is 56.8% above its average volume of 63763.
More news about B&S Group.
3. SANOFI (SAN.PA)
49.31% Payout Ratio
Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as dupixent, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers body lotions, anti-itch products, moisturizing and soothing lotions, body and foot creams, and eczema powders. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301 for Parkinson's disease; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer. Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Amunix Pharmaceuticals, Inc for T-cell engagers and cytokine therapies. It also enters in a strategic collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, SANOFI has a trailing twelve months EPS of €7.22.
PE Ratio
SANOFI has a trailing twelve months price to earnings ratio of 11.84. Meaning, the purchaser of the share is investing €11.84 for every euro of annual earnings.
Sales Growth
SANOFI’s sales growth is 4.2% for the present quarter and 0.3% for the next.
Moving Average
SANOFI’s value is way below its 50-day moving average of €96.48 and way below its 200-day moving average of €96.24.
Yearly Top and Bottom Value
SANOFI’s stock is valued at €85.47 at 06:10 EST, way under its 52-week high of €105.18 and above its 52-week low of €80.60.
More news about SANOFI.
4. AHOLD DEL (AD.AS)
47.37% Payout Ratio
Koninklijke Ahold Delhaize N.V. operates retail food stores and e-commerce primarily in the United States and Europe. The company's stores offer produce, dairy, meat, deli, bakery, seafood, and frozen products; grocery, dairy, and beer and wine; floral, pet food, health and beauty care, kitchen and cookware, gardening tools, general merchandise articles, electronics, newspapers and magazines, tobacco, etc.; gasoline; and pharmacy products. It operates its supermarkets, convenience stores, and online stores under the Food Lion, Stop & Shop, The GIANT Company, Hannaford, Giant Food, FreshDirect, Albert Heijn, bol.com, Etos, Gall & Gall, Delhaize, Albert, Alfa Beta Vassilopoulos, Mega Image, and Delhaize Serbia brands. The company was formerly known as Koninklijke Ahold N.V. and changed its name to Koninklijke Ahold Delhaize N.V. in July 2016. Koninklijke Ahold Delhaize N.V. was founded in 1867 and is headquartered in Zaandam, the Netherlands.
Earnings Per Share
As for profitability, AHOLD DEL has a trailing twelve months EPS of €2.28.
PE Ratio
AHOLD DEL has a trailing twelve months price to earnings ratio of 11.6. Meaning, the purchaser of the share is investing €11.6 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.26%.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Aug 11, 2023, the estimated forward annual dividend rate is 1.08 and the estimated forward annual dividend yield is 4.06%.
Yearly Top and Bottom Value
AHOLD DEL’s stock is valued at €26.45 at 06:10 EST, way under its 52-week high of €32.51 and higher than its 52-week low of €26.15.
More news about AHOLD DEL.
5. SEMAPA (SEM.LS)
43.74% Payout Ratio
Semapa – Sociedade de Investimento e Gestão, SGPS, S.A., through its subsidiaries, produces and sells uncoated woodfree (UWF) printing and writing paper. It operates through three segments: Pulp and Paper, Cement and Derivatives, and Environment. The company offers pulp and tissue paper; researches, develops, produces, and sells forestry and agricultural products; produces and sells bleached eucalyptus kraft pulp (BEKP), cork, and pine wood products; and produces and sells energy from thermal, natural gas, and biofuel sources. It is also involved in the production and sale of cement, ready-mixed concrete, aggregates, mortars, prefabricated concrete structures, hydraulic lime, and clinker products; and operation of quarries. In addition, the company offers environment related services comprising collection, packaging, sorting, unpacking, upgrading, recovery, and sale of animal by-products and food products containing animal origin substances for the production of fertilizers and animal feed, and oil products for the biodiesel market. It has operations in Portugal, rest of Europe, the United States, Africa, Asia, and Oceania. The company was incorporated in 1991 and is headquartered in Lisbon, Portugal.
Earnings Per Share
As for profitability, SEMAPA has a trailing twelve months EPS of €3.42.
PE Ratio
SEMAPA has a trailing twelve months price to earnings ratio of 3.95. Meaning, the purchaser of the share is investing €3.95 for every euro of annual earnings.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on May 30, 2023, the estimated forward annual dividend rate is 2.71 and the estimated forward annual dividend yield is 20.62%.
More news about SEMAPA.
6. TOTALENERGIES (TTE.PA)
38.68% Payout Ratio
TotalEnergies SE, a multi-energy company, produces and markets fuels, natural gas, and electricity in France, rest of Europe, North America, Africa, and internationally. It operates through Integrated Gas, Renewables & Power; Exploration & Production; Refining & Chemicals; and Marketing & Services segments. The Integrated Gas, Renewables & Power segment engages in integrated gas, including liquified natural gas (LNG), and low carbon electricity businesses; and upstream and midstream LNG activities. Its Exploration & Production segment offers carbon storage and nature-based solutions. The Refining & Chemicals segment provides refining, petrochemicals, and specialty chemicals; and supply and trading of oil, and marine shipping services. Its Marketing & Services segment engages in the supply and marketing of petroleum products. TotalEnergies SE was formerly known as TOTAL SE and changed its name to TotalEnergies SE in June 2021. The company was founded in 1924 and is headquartered in Courbevoie, France.
Earnings Per Share
As for profitability, TOTALENERGIES has a trailing twelve months EPS of €7.23.
PE Ratio
TOTALENERGIES has a trailing twelve months price to earnings ratio of 8.67. Meaning, the purchaser of the share is investing €8.67 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.66%.
Yearly Top and Bottom Value
TOTALENERGIES’s stock is valued at €62.67 at 06:10 EST, under its 52-week high of €64.55 and way above its 52-week low of €50.55.
Revenue Growth
Year-on-year quarterly revenue growth declined by 16.2%, now sitting on 228.13B for the twelve trailing months.
Sales Growth
TOTALENERGIES’s sales growth is negative 19% for the present quarter and negative 27.1% for the next.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Jan 2, 2024, the estimated forward annual dividend rate is 2.96 and the estimated forward annual dividend yield is 4.7%.
More news about TOTALENERGIES.
1. 1 (1)
1% Payout Ratio
1
Earnings Per Share
As for profitability, 1 has a trailing twelve months EPS of €1.
PE Ratio
1 has a trailing twelve months price to earnings ratio of 1. Meaning, the purchaser of the share is investing €1 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1%.
More news about 1.
